StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Vaccinex's EPS for the twelve months ending Dec 31, 2024 was -$8.88. For fiscal 2024 it was -$8.88. The highest annual figure on record is -$8.88 in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$8.88–
FY2023Dec 31, 2023-$43.68–
FY2022Dec 31, 2022-$98.05–
FY2021Dec 31, 2021-$163.80–
FY2020Dec 31, 2020-$323.40–
FY2019Dec 31, 2019-$518.70–
FY2018Dec 31, 2018-$1186.50–
FY2017Dec 31, 2017-$4179.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$1.05–
Q3 FY2024Sep 30, 2024-$2.83–
Q2 FY2024Jun 30, 2024-$3.10–
Q1 FY2024Mar 31, 2024-$2.94–
Q3 FY2023Sep 30, 2023-$15.25–
Q2 FY2023Jun 30, 2023-$24.54–
Q1 FY2023Mar 31, 2023-$20.89–
Q4 FY2022Dec 31, 2022-$23.35–
Q3 FY2022Sep 30, 2022-$23.38–
Q2 FY2022Jun 30, 2022-$27.30–
Q1 FY2022Mar 31, 2022-$25.20–
Q4 FY2021Dec 31, 2021-$31.57–
Q3 FY2021Sep 30, 2021-$35.70–
Q2 FY2021Jun 30, 2021-$44.10–
Q1 FY2021Mar 31, 2021-$54.60–
Q4 FY2020Dec 31, 2020-$60.46–
Q3 FY2020Sep 30, 2020-$92.40–
Q2 FY2020Jun 30, 2020-$81.90–
Q1 FY2020Mar 31, 2020-$94.50–
Q4 FY2019Dec 31, 2019-$89.86–
Q3 FY2019Sep 30, 2019-$117.60–
Q2 FY2019Jun 30, 2019-$161.70–
Q1 FY2019Mar 31, 2019-$165.90–
Q3 FY2018Sep 30, 2018-$195.30–
Q2 FY2018Jun 30, 2018-$1411.20–
Q1 FY2018Mar 31, 2018-$1497.30–
Q4 FY2017Dec 31, 2017-$493.33–
Q3 FY2017Sep 30, 2017-$1207.50–
Q2 FY2017Jun 30, 2017-$1081.50–

More Vaccinex figures

See a number that looks wrong?